Clinique La Prairie is opening a 52-room health resort at AMAALA, Saudi Arabia's mega wellness destination. Construction photos are circulating on X. Here's what we know and what it signals for the longevity industry.
Eli Lilly signed a $2.75B deal with Insilico Medicine for AI-generated drug candidates targeting age-related diseases. Big Pharma is now investing billions in longevity drug discovery. Here's what it means for clinics and patients.
Fountain Life is expanding from 4 to 7+ US locations in 2026, with new centers in Houston, Miami, and Los Angeles. Here's what the expansion means for the US longevity market and how their model compares.
Niagen Bioscience is partnering with OneSpaWorld to offer pharmaceutical-grade NAD+ IV therapy at 80+ medi-spa clinics on high-end cruise ships starting summer 2026. Is this democratization or dilution of longevity medicine?